Jun 15Leadership & CorporateMablink Bioscience appoints Pejvack Motlagh, M.D., as Chief Medical OfficerLyon, France, June 15, 2023 Mablink Bioscience (“Mablink”), a biotechnologycompany dedicated to advancing cancer therapy with...
Apr 28Leadership & CorporateMablink, in the supplement of the March 2023 issue of "La Jaune et la Rouge"Interview with Jean-Guillaume LAFAY, CEO of Mablink, in the supplement of the March 2023 issue of "La Jaune et la Rouge" on the topic...
Mar 14Science & MedicineMablink Bioscience to Present Promising Preclinical Data for Lead ADC Candidate MBK-103 at the AACRMablink's poster will include in vivo efficacy data in mouse models and safety data in non-human primates